INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543904	ISIN Demat INE634S01028	Book Value 354.77	NSE Symbol MANKIND	Dividend Yield (%) 0	Market Cap (₹ Cr.) 98,296.18	P/E 52.17	EPS 45.66	Face Value 1

Particulars (₹ Cr)	Mar 2025	Dec 2024	Sep 2024	Jun 2024

Gross Sales/Income from operations	2126.59	2414.41	2529.74	2403.26
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,126.59	2,414.41	2,529.74	2,403.26
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	2,126.59	2,414.41	2,529.74	2,403.26
Total Expenses	1,754.91	1,759.42	1,863.13	1,914.46
Cost of Sales	557.48	654.37	703.37	686.49
Employee Cost	536.75	530.68	525.86	522.10
Depreciation, amortization and depletion expense	105.24	91.11	85.42	83.40
Provisions & Write Offs	15.82	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	539.62	483.26	548.48	622.47
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	371.68	654.99	666.61	488.80
Other Income	219.32	70.37	105.76	94.83
Profit from ordinary activities before finance costs and exceptional items	591.00	725.36	772.37	583.63
Finance Costs	162.25	200.27	1.92	6.26
Profit from ordinary activities after finance costs but before exceptional items	428.75	525.09	770.45	577.37
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	428.75	525.09	770.45	577.37
Total Tax	46.29	113.07	168.01	93.12
Net profit from Ordinary Activities After Tax	382.46	412.02	602.44	484.25
Profit / (Loss) from Discontinued Operations	0.00	0.00	31.99	29.24
Net profit from Ordinary Activities/Discontinued Operations After Tax	382.46	412.02	634.43	513.49
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	382.46	412.02	634.43	513.49
Other Comprehensive Income	-3.27	9.41	0.17	-1.34
Total Comprehensive Income	379.19	421.43	634.60	512.15
Equity	41.26	40.06	40.06	40.06
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	9.27	10.35	15.84	12.82
EPS before Exceptional/Extraordinary items-Diluted	9.25	10.33	15.81	12.80
EPS after Exceptional/Extraordinary items-Basic	9.27	10.35	15.84	12.82
EPS after Exceptional/Extraordinary items-Diluted	9.25	10.33	15.81	12.80
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00